注射可能型ベンゾジアゼピンの世界市場2020年-2030年

◆英語タイトル:Injectable Benzodiazepine Market - Global Industry Analysis and Opportunity Assessment, 2020-2030
◆商品コード:FMI20OT030
◆発行会社(リサーチ会社):Future Market Insights
◆発行日:2020年6月27日
◆ページ数:236
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Individual Price(1名様閲覧用)USD5,000 ⇒換算¥540,000見積依頼/購入/質問フォーム
Corporate Price(同一法人内共有可)USD7,500 ⇒換算¥810,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はFuture Market Insights社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Future Market Insights社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本調査レポートでは、注射可能型ベンゾジアゼピンの市場を広く調査・分析し、エグゼクティブサマリー、市場概要、主要市場動向、市場背景、市場状況、市場価値分析・予測、医薬品クラス別(ジアゼパム、ロラゼパム、ミダゾラム)分析、疾患別分析、作用時間別分析、流通チャネル別分析、地域別分析、市場構造分析、競争分析、仮定、調査手法と今後の方向性を明らかに致します。
・エグゼクティブサマリー
・市場概要
・主要市場動向
・市場背景
・市場状況
・市場価値分析・予測
・注射可能型ベンゾジアゼピンの世界市場規模:医薬品クラス別(ジアゼパム、ロラゼパム、ミダゾラム)
・注射可能型ベンゾジアゼピンの世界市場規模:疾患別
・注射可能型ベンゾジアゼピンの世界市場規模:作用時間別
・注射可能型ベンゾジアゼピンの世界市場規模:流通チャネル別
・注射可能型ベンゾジアゼピンの世界市場規模:地域別
・市場構造分析
・競争分析
・仮定
・調査手法
【レポートの概要】

A recent market study published by Future Market Insights (FMI) on the Injectable benzodiazepines market offers global industry analysis for 2015-2019 & opportunity assessment for 2020-2030. The report consists of a comprehensive assessment of the most important market dynamics. On conducting thorough research on the historical as well as current growth parameters of the market, growth prospects of the market are obtained with utmost precision.

The report features unique and salient factors that may make a huge impact on the development of the injectable benzodiazepines market during the forecast period. It can help market players modify their manufacturing and marketing strategies to envisage maximum growth in the market in the coming years. The report provides detailed information about the current and future growth prospects of the market in the most comprehensive way for better understanding of readers.

Key Segments of Injectable benzodiazepines Market

FMI’s study on the injectable benzodiazepines market offers information divided into three important segments— drug class, indication, time of action, distribution channel, and region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.

[Drug Class]
Diazepam
Lorazepam
Midazolam

[Time of Action]
Short Acting
Long Acting

[Indication]
Agitation & Aggression
Anxiety
Alcohol Withdrawal
Muscle Spasm
Seizures
Tetanus
Sedation
Anaesthesia
Insomnia
Status Epilepticus

[Distribution Channel]
Hospital
Ambulatory Surgical centers
Diagnostics Centers

[Region]
North America
Latin America
Europe
East Asia
South Asia
Oceania
Middle East and Africa

Chapter 01 – Executive Summary
The report commences with the executive summary of the injectable benzodiazepines market report, which includes the snapshot of key findings and statistics of the market. It also includes the market value (US$ million) estimates of the leading segments of the market as well as the key trends impacting the market.

Chapter 02 – Market Overview
Readers can find detailed taxonomy and product definition of the injectable benzodiazepines market in this chapter. This section also provides the key inclusions and exclusions of the market that help readers understand basics of the market.

Chapter 03 – Key Market Trends
This section highlights the key trends impacting the market, which will help readers understand the current trends and their impact on market growth.

Chapter 04 – Market Background
This chapter explains the macroeconomic factors that are expected to influence the growth of the injectable benzodiazepines market during the forecast period. It also highlights the major forecast factors that will shape market growth. Also, the value chain analysis is given. Besides, it provides key dynamics of the market which include the drivers, restraints, and opportunities.

This chapter is expected to enable readers to understand the factors that are propelling the growth of the injectable benzodiazepines market, as well as the ones that are likely to hamper the growth of the market. The opportunity analysis for the injectable benzodiazepines will help readers understand the market opportunities, based on which they can plan their strategies.

Chapter 05 – Market Context
This section highlights the key contexts of the market such as product adoption/usage analysis, product USPs/ features, regulatory scenario, key strategies by the leading manufacturers, supply-chain analysis, which will help readers to gain extensive knowledge about the injectable benzodiazepines market.

Chapter 06 – Global Injectable benzodiazepines Market Value (US$) Analysis 2015-2019 and Forecast 2020-2030
This section explains the global market value analysis and forecast for the market during the forecast period. Along with the historical market and opportunity analysis of the future. Readers can also find the absolute $ opportunity for the current year (2020), and an incremental $ opportunity for the forecast period (2020–2030).

Chapter 07 – Global Injectable benzodiazepines Market Analysis (2015-2019) & Opportunity Assessment (2020-2030), By Drug Class
Based on product type, the market is segmented into diazepam, lorazepam and midazolam. In this chapter, readers can find a detailed analysis of the market by different drug class of injectable benzodiazepines and their growth over the forecast period.

Chapter 08 – Global Injectable benzodiazepines Market Analysis (2015-2019) & Opportunity Assessment (2020-2030), By Indication
Based on indication, the market spans agitation & aggression, anxiety, alcohol withdrawal, muscle spasm, seizures, tetanus, sedation, anesthesia insomnia, and status epilepticus.

Chapter 09 – Global Injectable benzodiazepines Market Analysis (2015-2019) & Opportunity Assessment (2020-2030), By Time of Action
Based on time of action, the market comprises short acting and long acting.

Chapter 10 – Global Injectable benzodiazepines Market Analysis (2015-2019) & Opportunity Assessment (2020-2030), By Distribution Channel
Based on distribution channel, the market consists of Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies. In this chapter, readers can find a detailed analysis of the market by distribution channel and their growth over the forecast period.

Chapter 11 – Global Injectable benzodiazepines Market Analysis 2015-2019 & Opportunity Assessment 2020-2030, By Region
This chapter explains how the market will grow across various regions such as North America, Latin America, Europe, East Asia, South Asia, Oceania, and the Middle East & Africa (MEA).

Chapter 12 – North America Injectable benzodiazepines Market Analysis 2015-2019 & Opportunity Assessment 2020-2030
This chapter includes a detailed analysis of the growth of North America’s market along with the country-wise assessment including the US and Canada. Readers can also find key takeaways of this region, and market growth based on drug class, indication, time of action, distribution channel, and country of injectable benzodiazepines in the North American region.

Chapter 13 – Latin America Injectable benzodiazepines Market Analysis 2015-2019 & Opportunity Assessment 2020-2030
This chapter includes the growth prospects of the market in leading countries such as Brazil, Mexico, and the rest of Latin America. Readers can find thorough information about the growth parameters of Latin America’s injectable benzodiazepines market between 2020 and 2030.

Chapter 14 –Europe Injectable benzodiazepines Market Analysis 2015-2019 & Opportunity Assessment 2020-2030
Important growth prospects of the market based on drug class, indication, time of action, distribution channel and country in several European countries such as the U.K., Germany, France, Italy, Spain, Russia, BENELUX, and Rest of Europe are included in this chapter.

Chapter 15– South Asia Injectable benzodiazepines Market Analysis 2015-2019 and Forecast 2020-2030
India, Indonesia, Malaysia, Thailand, and the rest of South Asia are the leading countries/regions in South Asia that are the prime subjects of assessment to obtain the growth prospects of the South Asia market. In this chapter, readers can find thorough information about the growth parameters of South Asia’s injectable benzodiazepines market by 2030.

Chapter 16 – East Asia Injectable benzodiazepines Market Analysis 2015-2019 and Forecast 2020-2030
Detailed information about incremental opportunity, Y-O-Y growth, and regional trends that are impacting the growth of East Asia’s injectable benzodiazepines market are included in this chapter. It also includes the growth prospects of the market in leading East Asian countries such as China, Japan, and South Korea.

Chapter 17 – Oceania Injectable benzodiazepines Market Analysis 2014–2018 and Forecast 2020–2030
This chapter consists of important parameters that have a huge impact on the growth of the market in Oceania, based on market segmentation, during the forecast period. The chapter also provides an overview of the drivers, restraints, and trends in Oceania’s injectable benzodiazepines market.

Chapter 18 – MEA Injectable benzodiazepines Market Analysis 2015-2019 & Opportunity Assessment 2020-2030
This chapter provides information on how the market will grow in the major countries in MEA, such as GCC Countries, South Africa, Northern Africa, Turkey, and Rest of MEA between 2020 and 2030.

Chapter 19 – Key and Emerging Countries Injectable benzodiazepines Market Analysis 2015–2019 and Forecast 2020–2030
This chapter includes the growth prospects of the market in countries such as U.S., Canada, Brazil, Germany, China, India etc. Readers can find thorough information about the growth parameters of injectable benzodiazepines market between 2020 and 2030 in these countries.

Chapter 20 – Market Structure Analysis
This chapter covers the market analysis of competitors based on revenue tiers, single point view of portfolio across industry segments, and their relative market position.

Chapter 21 – Competition Analysis
In this chapter, readers can find a comprehensive list of all the leading stakeholders in the injectable benzodiazepines market, along with detailed information about each company, including company overview, revenue shares, strategic overview, and recent company developments. Players featured in the market report include Pfizer Inc., Hikma Pharmaceuticals (West-Ward Pharmaceuticals), Taj Pharmaceuticals Limited, Dash Pharmaceuticals LLC, Hameln pharma ltd, F. Hoffmann-La Roche Ltd, AdvaCare Pharma, Taj Pharmaceuticals Ltd., Troy Laboratories Pty Ltd, Martin Dow, Sun Pharmaceutical Industries Limited, Intas Pharmaceuticals Limited, Teva Pharmaceutical Industries Ltd. (Actavis Pharma, Inc.),and Akorn Inc among others.

Chapter 22– Assumptions and Acronyms Used
This chapter includes a list of acronyms and assumptions that provide a base to the information and statistics included in the report.

Chapter 23 – Research Methodology
This chapter helps readers understand the research methodology followed to obtain various conclusions, important qualitative information, and quantitative information about the injectable benzodiazepines market.

【レポートの目次】

1. Executive Summary

1.1. Global Market Outlook

1.2. Demand Side Trends

1.3. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy

2.2. Market Definition / Scope / Limitations

2.3. Inclusions and Exclusions

3. Key Market Trends

3.1. Key Trends Impacting the Market

3.2. Product Innovation / Development Trends

4. Market Background

4.1. Macro-Economic Factors

4.1.1. Global GDP Growth Outlook

4.1.2. Per Capita Healthcare Expenditure Outlook

4.1.3. Overall Psychoactive Drugs Market

4.2. Forecast Factors – Relevance & Impact

4.2.1. Increasing Incidence of Anxiety, Seizures, Insomnia

4.2.2. Increasing Usage as Anaesthesia

4.2.3. Dose Per Case

4.2.4. Treatment Cost

4.3. Market Dynamics

4.3.1. Drivers

4.3.2. Restraints

4.3.3. Opportunities

5. Market Context

5.1. Product Adoption / Usage Analysis By Indication

5.2. Disease Epidemiology, By Region

5.3. Regulatory Scenario

5.4. Reimbursement Landscape

5.5. Key Promotional Strategies, By Manufacturers

5.6. COVID19 Crisis Analysis

5.6.1. Current COVID19 Statistics and Probable Future Impact

5.6.2. Current GDP Projection and Probable Impact

5.6.3. COVID19 and Impact Analysis

5.6.3.1. Revenue By Class

5.6.3.2. Revenue By Country

5.6.4. 2020 Market Scenario

5.6.5. Quarter by Quarter Forecast

5.6.6. Projected recovery Quarter

5.6.7. Recovery Scenario – Short term, Midterm and Long Term Impact

6. Global Injectable Benzodiazepines Market Value (US$ Mn) Analysis 2015-2019 and Forecast, 2020-2030

6.1. Historical Market Value (US$ Mn) Analysis, 2015-2019

6.2. Current and Future Market Value (US$ Mn) Projections, 2020-2030

6.2.1. Y-o-Y Growth Trend Analysis

6.2.2. Opportunity Analysis, 2020-2030

7. Global Injectable Benzodiazepines Market Analysis 2015-2019 and Forecast 2020-2030, By Drug Class

7.1. Introduction / Key Findings

7.2. Historical Market Size (US$ Mn) Analysis By Drug Class , 2015–2019

7.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Drug Class , 2020-2030

7.3.1. Diazepam

7.3.2. Lorazepam

7.3.3. Midazolam

7.4. Market Attractiveness Analysis By Drug Class

8. Global Injectable Benzodiazepines Market Analysis 2015-2019 and Forecast 2020-2030, by Indication

8.1. Introduction / Key Findings

8.2. Historical Market Size (US$ Mn) Analysis By Indication, 2014 – 2018

8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Indication, 2019 – 2030

8.3.1. Agitation & Aggression

8.3.2. Anxiety

8.3.3. Alcohol Withdrawal

8.3.4. Muscle Spasm

8.3.5. Seizures

8.3.6. Tetanus

8.3.7. Sedation

8.3.8. Local Anaesthesia

8.3.9. Insomnia

8.3.10. Status Epilepticus

8.4. Market Attractiveness Analysis By Indication

9. Global Injectable Benzodiazepines Market Analysis 2015-2019 and Forecast 2020-2030, By Time of Action

9.1. Introduction / Key Findings

9.2. Historical Market Size (US$ Mn) Analysis By Time of Action, 2014 – 2018

9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Time of Action, 2019 – 2030

9.3.1. Short Acting

9.3.2. Long Acting

9.4. Market Attractiveness Analysis By Time of Action

10. Global Injectable Benzodiazepines Market Analysis 2015-2019 and Forecast 2020-2030, by Distribution Channel

10.1. Introduction / Key Findings

10.2. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2014 – 2018

10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Distribution Channel, 2019 – 2030

10.3.1. Hospital Pharmacies

10.3.2. Retail Pharmacies

10.3.3. Mail Order Pharmacies/Online Pharmacies

10.4. Market Attractiveness Analysis By Distribution Channel

11. Global Injectable Benzodiazepines Market Analysis 2015-2019 and Forecast 2020-2030, by Region

11.1. Introduction / Key Findings

11.2. Historical Market Size (US$ Mn) Analysis By Region, 2015–2019

11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Region, 2020-2030

11.3.1. North America

11.3.2. Latin America

11.3.3. Europe

11.3.4. East Asia

11.3.5. South Asia

11.3.6. Oceania

11.3.7. Middle East and Africa

11.4. Market Attractiveness Analysis By Region

12. North America Injectable Benzodiazepines Market Analysis 2015-2019 and Forecast 2020-2030

12.1. Introduction

12.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015–2019

12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020-2030

12.3.1. By Country

12.3.1.1. U.S.

12.3.1.2. Canada

12.3.2. By Drug Class

12.3.3. By Indication

12.3.4. By Time of Action

12.3.5. By Distribution Channel

12.4. Market Attractiveness Analysis

12.5. Key Market Participants – Intensity Mapping

12.6. Drivers and Restraints – Impact Analysis

13. Latin America Injectable Benzodiazepines Market Analysis 2015-2019 and Forecast 2020-2030

13.1. Introduction

13.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015–2019

13.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020-2030

13.3.1. By Country

13.3.1.1. Brazil

13.3.1.2. Mexico

13.3.1.3. Argentina

13.3.1.4. Rest of Latin America

13.3.2. By Drug Class

13.3.3. By Indication

13.3.4. By Time of Action

13.3.5. By Distribution Channel

13.4. Market Attractiveness Analysis

13.5. Key Market Participants – Intensity Mapping

13.6. Drivers and Restraints – Impact Analysis

14. Europe Injectable Benzodiazepines Market Analysis 2015-2019 and Forecast 2020-2030

14.1. Introduction

14.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015–2019

14.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020-2030

14.3.1. By Country

14.3.1.1. Germany

14.3.1.2. Italy

14.3.1.3. France

14.3.1.4. U.K.

14.3.1.5. Spain

14.3.1.6. BENELUX

14.3.1.7. Russia

14.3.1.8. Rest of Europe

14.3.2. By Drug Class

14.3.3. By Indication

14.3.4. By Time of Action

14.3.5. By Distribution Channel

14.4. Market Attractiveness Analysis

14.5. Key Market Participants – Intensity Mapping

14.6. Drivers and Restraints – Impact Analysis

15. South Asia Injectable Benzodiazepines Market Analysis 2015-2019 and Forecast 2020-2030

15.1. Introduction

15.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015–2019

15.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020-2030

15.3.1. By Country

15.3.1.1. India

15.3.1.2. Thailand

15.3.1.3. Indonesia

15.3.1.4. Malaysia

15.3.1.5. Rest of South Asia

15.3.2. By Drug Class

15.3.3. By Indication

15.3.4. By Time of Action

15.3.5. By Distribution Channel

15.4. Market Attractiveness Analysis

15.5. Key Market Participants – Intensity Mapping

15.6. Drivers and Restraints – Impact Analysis

16. East Asia Injectable Benzodiazepines Market Analysis 2015-2019 and Forecast 2020-2030

16.1. Introduction

16.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015–2019

16.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020-2030

16.3.1. By Country

16.3.1.1. China

16.3.1.2. Japan

16.3.1.3. South Korea

16.3.2. By Drug Class

16.3.3. By Indication

16.3.4. By Time of Action

16.3.5. By Distribution Channel

16.4. Market Attractiveness Analysis

16.5. Key Market Participants – Intensity Mapping

16.6. Drivers and Restraints – Impact Analysis

17. Oceania Injectable Benzodiazepines Market Analysis 2015-2019 and Forecast 2020-2030

17.1. Introduction

17.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015–2019

17.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020-2030

17.3.1. By Country

17.3.1.1. Australia

17.3.1.2. New Zealand

17.3.2. By Drug Class

17.3.3. By Indication

17.3.4. By Time of Action

17.3.5. By Distribution Channel

17.4. Market Attractiveness Analysis

17.5. Key Market Participants – Intensity Mapping

17.6. Drivers and Restraints – Impact Analysis

18. Middle East and Africa Injectable Benzodiazepines Market Analysis 2015-2019 and Forecast 2020-2030

18.1. Introduction

18.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015–2019

18.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020-2030

18.3.1. By Country

18.3.1.1. GCC Countries

18.3.1.2. Turkey

18.3.1.3. South Africa

18.3.1.4. Rest of Middle East and Africa

18.3.2. By Drug Class

18.3.3. By Indication

18.3.4. By Time of Action

18.3.5. By Distribution Channel

18.4. Market Attractiveness Analysis

18.5. Key Market Participants – Intensity Mapping

18.6. Drivers and Restraints – Impact Analysis

19. Key and Emerging Countries Injectable Benzodiazepines Market Analysis 2015-2019 and Forecast 2020-2030

19.1. Introduction

19.1.1. Market Value Proportion Analysis, By Key Countries

19.1.2. Global Vs. Country Growth Comparison

19.2. U.S. Injectable Benzodiazepines Market Analysis

19.2.1. By Drug Class

19.2.2. By Indication

19.2.3. By Time of Action

19.2.4. By Distribution Channel

19.3. Canada Injectable Benzodiazepines Market Analysis

19.3.1. By Drug Class

19.3.2. By Indication

19.3.3. By Time of Action

19.3.4. By Distribution Channel

19.4. Mexico Injectable Benzodiazepines Market Analysis

19.4.1. By Drug Class

19.4.2. By Indication

19.4.3. By Time of Action

19.4.4. By Distribution Channel

19.5. Brazil Injectable Benzodiazepines Market Analysis

19.5.1. By Drug Class

19.5.2. By Indication

19.5.3. By Time of Action

19.5.4. By Distribution Channel

19.6. U.K. Injectable Benzodiazepines Market Analysis

19.6.1. By Drug Class

19.6.2. By Indication

19.6.3. By Time of Action

19.6.4. By Distribution Channel

19.7. Germany Injectable Benzodiazepines Market Analysis

19.7.1. By Drug Class

19.7.2. By Indication

19.7.3. By Time of Action

19.7.4. By Distribution Channel

19.8. France Injectable Benzodiazepines Market Analysis

19.8.1. By Drug Class

19.8.2. By Indication

19.8.3. By Time of Action

19.8.4. By Distribution Channel

19.9. Italy Injectable Benzodiazepines Market Analysis

19.9.1. By Drug Class

19.9.2. By Indication

19.9.3. By Time of Action

19.9.4. By Distribution Channel

19.10. Spain Injectable Benzodiazepines Market Analysis

19.10.1. By Drug Class

19.10.2. By Indication

19.10.3. By Time of Action

19.10.4. By Distribution Channel

19.11. BENELUX Injectable Benzodiazepines Market Analysis

19.11.1. By Drug Class

19.11.2. By Indication

19.11.3. By Time of Action

19.11.4. By Distribution Channel

19.12. Russia Injectable Benzodiazepines Market Analysis

19.12.1. By Drug Class

19.12.2. By Indication

19.12.3. By Time of Action

19.12.4. By Distribution Channel

19.13. China Injectable Benzodiazepines Market Analysis

19.13.1. By Drug Class

19.13.2. By Indication

19.13.3. By Time of Action

19.13.4. By Distribution Channel

19.14. Japan Injectable Benzodiazepines Market Analysis

19.14.1. By Drug Class

19.14.2. By Indication

19.14.3. By Time of Action

19.14.4. By Distribution Channel

19.15. South Korea Injectable Benzodiazepines Market Analysis

19.15.1. By Drug Class

19.15.2. By Indication

19.15.3. By Time of Action

19.15.4. By Distribution Channel

19.16. India Injectable Benzodiazepines Market Analysis

19.16.1. By Drug Class

19.16.2. By Indication

19.16.3. By Time of Action

19.16.4. By Distribution Channel

19.17. ASEAN Injectable Benzodiazepines Market Analysis

19.17.1. By Drug Class

19.17.2. By Indication

19.17.3. By Time of Action

19.17.4. By Distribution Channel

19.18. Australia Injectable Benzodiazepines Market Analysis

19.18.1. By Drug Class

19.18.2. By Indication

19.18.3. By Time of Action

19.18.4. By Distribution Channel

19.19. New Zealand Injectable Benzodiazepines Market Analysis

19.19.1. By Drug Class

19.19.2. By Indication

19.19.3. By Time of Action

19.19.4. By Distribution Channel

19.20. GCC Countries Injectable Benzodiazepines Market Analysis

19.20.1. By Drug Class

19.20.2. By Indication

19.20.3. By Time of Action

19.20.4. By Distribution Channel

19.21. Turkey Injectable Benzodiazepines Market Analysis

19.21.1. By Drug Class

19.21.2. By Indication

19.21.3. By Time of Action

19.21.4. By Distribution Channel

19.22. South Africa Injectable Benzodiazepines Market Analysis

19.22.1. By Drug Class

19.22.2. By Indication

19.22.3. By Time of Action

19.22.4. By Distribution Channel

20. Market Structure Analysis

20.1. Market Analysis by Tier of Companies

20.2. Market Share Analysis of Top Players

20.3. Market Presence Analysis

20.3.1. Regional Footprint by Players

20.3.2. Product Foot print by Players

21. Competition Analysis

21.1. Competition Dashboard

21.2. Competition Benchmarking

21.3. Competition Deep Dive

21.3.1. Pfizer Inc.

21.3.1.1. Overview

21.3.1.2. Product Portfolio

21.3.1.3. Profitability by Market Segments (Product/Channel/Region)

21.3.1.4. Sales Footprint

21.3.1.5. Strategy Overview

21.3.1.5.1. Marketing Strategy

21.3.1.5.2. Product Strategy

21.3.1.5.3. Channel Strategy

21.3.2. Hikma Pharmaceuticals (West-Ward Pharmaceuticals)

21.3.2.1. Overview

21.3.2.2. Product Portfolio

21.3.2.3. Profitability by Market Segments (Product/Channel/Region)

21.3.2.4. Sales Footprint

21.3.2.5. Strategy Overview

21.3.2.5.1. Marketing Strategy

21.3.2.5.2. Product Strategy

21.3.2.5.3. Channel Strategy

21.3.3. Taj Pharmaceuticals Limited

21.3.3.1. Overview

21.3.3.2. Product Portfolio

21.3.3.3. Profitability by Market Segments (Product/Channel/Region)

21.3.3.4. Sales Footprint

21.3.3.5. Strategy Overview

21.3.3.5.1. Marketing Strategy

21.3.3.5.2. Product Strategy

21.3.3.5.3. Channel Strategy

21.3.4. Accord Healthcare Ltd

21.3.4.1. Overview

21.3.4.2. Product Portfolio

21.3.4.3. Profitability by Market Segments (Product/Channel/Region)

21.3.4.4. Sales Footprint

21.3.4.5. Strategy Overview

21.3.4.5.1. Marketing Strategy

21.3.4.5.2. Product Strategy

21.3.4.5.3. Channel Strategy

21.3.5. Dash Pharmaceuticals LLC

21.3.5.1. Overview

21.3.5.2. Product Portfolio

21.3.5.3. Profitability by Market Segments (Product/Channel/Region)

21.3.5.4. Sales Footprint

21.3.5.5. Strategy Overview

21.3.5.5.1. Marketing Strategy

21.3.5.5.2. Product Strategy

21.3.5.5.3. Channel Strategy

21.3.6. hameln pharma ltd

21.3.6.1. Overview

21.3.6.2. Product Portfolio

21.3.6.3. Profitability by Market Segments (Product/Channel/Region)

21.3.6.4. Sales Footprint

21.3.6.5. Strategy Overview

21.3.6.5.1. Marketing Strategy

21.3.6.5.2. Product Strategy

21.3.6.5.3. Channel Strategy

21.3.7. F. Hoffmann-La Roche Ltd

21.3.7.1. Overview

21.3.7.2. Product Portfolio

21.3.7.3. Profitability by Market Segments (Product/Channel/Region)

21.3.7.4. Sales Footprint

21.3.7.5. Strategy Overview

21.3.7.5.1. Marketing Strategy

21.3.7.5.2. Product Strategy

21.3.7.5.3. Channel Strategy

21.3.8. AdvaCare Pharma

21.3.8.1. Overview

21.3.8.2. Product Portfolio

21.3.8.3. Profitability by Market Segments (Product/Channel/Region)

21.3.8.4. Sales Footprint

21.3.8.5. Strategy Overview

21.3.8.5.1. Marketing Strategy

21.3.8.5.2. Product Strategy

21.3.8.5.3. Channel Strategy

21.3.9. Troy Laboratories Pty Ltd

21.3.9.1. Overview

21.3.9.2. Product Portfolio

21.3.9.3. Profitability by Market Segments (Product/Channel/Region)

21.3.9.4. Sales Footprint

21.3.9.5. Strategy Overview

21.3.9.5.1. Marketing Strategy

21.3.9.5.2. Product Strategy

21.3.9.5.3. Channel Strategy

21.3.10. Martin Dow

21.3.10.1. Overview

21.3.10.2. Product Portfolio

21.3.10.3. Profitability by Market Segments (Product/Channel/Region)

21.3.10.4. Sales Footprint

21.3.10.5. Strategy Overview

21.3.10.5.1. Marketing Strategy

21.3.10.5.2. Product Strategy

21.3.10.5.3. Channel Strategy

21.3.11. Sun Pharmaceutical Industries Limited

21.3.11.1. Overview

21.3.11.2. Product Portfolio

21.3.11.3. Profitability by Market Segments (Product/Channel/Region)

21.3.11.4. Sales Footprint

21.3.11.5. Strategy Overview

21.3.11.5.1. Marketing Strategy

21.3.11.5.2. Product Strategy

21.3.11.5.3. Channel Strategy

21.3.12. Intas Pharmaceuticals Limited

21.3.12.1. Overview

21.3.12.2. Product Portfolio

21.3.12.3. Profitability by Market Segments (Product/Channel/Region)

21.3.12.4. Sales Footprint

21.3.12.5. Strategy Overview

21.3.12.5.1. Marketing Strategy

21.3.12.5.2. Product Strategy

21.3.12.5.3. Channel Strategy

21.3.13. Teva Pharmaceutical Industries Ltd. (Actavis Pharma, Inc.)

21.3.13.1. Overview

21.3.13.2. Product Portfolio

21.3.13.3. Profitability by Market Segments (Product/Channel/Region)

21.3.13.4. Sales Footprint

21.3.13.5. Strategy Overview

21.3.13.5.1. Marketing Strategy

21.3.13.5.2. Product Strategy

21.3.13.5.3. Channel Strategy

21.3.14. Akorn Inc

21.3.14.1. Overview

21.3.14.2. Product Portfolio

21.3.14.3. Profitability by Market Segments (Product/Channel/Region)

21.3.14.4. Sales Footprint

21.3.14.5. Strategy Overview

21.3.14.5.1. Marketing Strategy

21.3.14.5.2. Product Strategy

21.3.14.5.3. Channel Strategy

22. Assumptions and Acronyms Used

23. Research Methodology

Table 01: Global Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030 By Drug Class

Table 02: Global Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030 By Indication

Table 03: Global Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030 By Time of Action

Table 04: Global Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030 By Distribution Channel

Table 05: Global Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030 By Region

Table 06: North America Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Country

Table 07: North America Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Drug Class

Table 08: North America Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Indication

Table 09: North America Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Time of Action

Table 10: North America Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Distribution Channel

Table 11: Latin America Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Country

Table 12: Latin America Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Drug Class

Table 13: Latin America Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Indication

Table 14: Latin America Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Time of Action

Table 15: Latin America Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Distribution Channel

Table 16: Europe Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Country

Table 17: Europe Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Drug Class

Table 18: Europe Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Indication

Table 19: Europe Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Time of Action

Table 20: Europe Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Distribution Channel

Table 21: South Asia Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Country

Table 22: South Asia Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Drug Class

Table 23: South Asia Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Indication

Table 24: South Asia Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Time of Action

Table 25: South Asia Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Distribution Channel

Table 26: East Asia Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Country

Table 27: East Asia Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Drug Class

Table 28: East Asia Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Indication

Table 29: East Asia Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Time of Action

Table 30: East Asia Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Distribution Channel

Table 31: Oceania Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Country

Table 32: Oceania Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Drug Class

Table 33: Oceania Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Indication

Table 34: Oceania Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Time of Action

Table 35: Oceania Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Distribution Channel

Table 36: MEA Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Country

Table 37: MEA Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Drug Class

Table 38: MEA Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Indication

Table 39: MEA Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Time of Action

Table 40: MEA Injectable Benzodiazepines Drugs Market Value (US$ Mn) Analysis 2015–2019 and Forecast 2020-2030 By Distribution Channel

Figure 01: Global Injectable Benzodiazepines Market Value Share, By Drug Class, 2019 (A)

Figure 02: Global Injectable Benzodiazepines Market Value Share, By Indication, 2019 (A)

Figure 03: Global Injectable Benzodiazepines Market Value Share, By Time of Action, 2019 (A)

Figure 04: Global Injectable Benzodiazepines Market Value Share, By Distribution Channel, 2019 (A)

Figure 05: Global Injectable Benzodiazepines drugs Market Value Analysis 2015-2021 & 2030

Figure 06: Global Injectable Benzodiazepines drugs Market Y-O-Y Growth Analysis By Region

Figure 07: Global Injectable Benzodiazepines Drugs Market Value Analysis and Forecast, 2020–2030 (US$ Mn)

Figure 08: Global Injectable Benzodiazepines Drugs Market Absolute $ Opportunity (US$ Mn), 2015–2019

Figure 09: Global Injectable Benzodiazepines Drugs Market Absolute $ Opportunity (US$ Mn), 2020–2030

Figure 10: Global Injectable Benzodiazepines Drugs Market Share Analysis (%) By Drug Class, 2020 & 2030

Figure 11: Global Injectable Benzodiazepines Drugs Market Y-o-Y Growth (%) By Drug Class, 2020–2030

Figure 12: Global Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Drug Class, 2020–2030

Figure 13: Global Injectable Benzodiazepines Drugs Market Share Analysis (%) By Indication, 2020 & 2030

Figure 14: Global Injectable Benzodiazepines Drugs Market Y-o-Y Growth (%) By Indication, 2020–2030

Figure 15: Global Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Indication, 2020–2030

Figure 16: Global Injectable Benzodiazepines Drugs Market Share Analysis (%) By Time of Action, 2020 & 2030

Figure 17: Global Injectable Benzodiazepines Drugs Market Y-o-Y Growth (%) By Time of Action, 2020–2030

Figure 18: Global Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Time of Action, 2020–2030

Figure 19: Global Injectable Benzodiazepines Drugs Market Share Analysis (%) By Distribution Channel, 2020 & 2030

Figure 20: Global Injectable Benzodiazepines Drugs Market Y-o-Y Growth (%) By Distribution Channel, 2020–2030

Figure 21: Global Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Distribution Channel, 2020–2030

Figure 22: Global Injectable Benzodiazepines Drugs Market Share Analysis (%) By Region, 2020 & 2030

Figure 23: Global Injectable Benzodiazepines Drugs Market Y-o-Y Growth (%) By Region, 2020–2030

Figure 24: Global Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Region, 2020–2030

Figure 25: North America Injectable Benzodiazepines Drugs Market Value Analysis, 2015–2019

Figure 26: North America Injectable Benzodiazepines Drugs Market Forecast & Y-o-Y growth, 2020–2030

Figure 27: North America Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Country, 2020-2030

Figure 28: North America Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Drug Class, 2020-2030

Figure 29: North America Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Indication, 2020-2030

Figure 30: North America Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Time of Action, 2020-2030

Figure 31: North America Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Distribution Channel, 2020-2030

Figure 32: Latin America Injectable Benzodiazepines Drugs Market Value Analysis, 2015–2019

Figure 33: Latin America Injectable Benzodiazepines Drugs Market Forecast & Y-o-Y growth, 2020–2030

Figure 34: Latin America Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Country, 2020-2030

Figure 35: Latin America Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Drug Class, 2020-2030

Figure 36: Latin America Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Indication, 2020-2030

Figure 37: Latin America Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Time of Action, 2020-2030

Figure 38: Latin America Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Distribution Channel, 2020-2030

Figure 39: Europe Injectable Benzodiazepines Drugs Market Value Analysis, 2015–2019

Figure 40: Europe Injectable Benzodiazepines Drugs Market Forecast & Y-o-Y growth, 2020–2030

Figure 41: Europe Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Country, 2020-2030

Figure 42: Europe Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Drug Class, 2020-2030

Figure 43: Europe Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Indication, 2020-2030

Figure 44: Europe Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Time of Action, 2020-2030

Figure 45: Europe Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Distribution Channel, 2020-2030

Figure 46: South Asia Injectable Benzodiazepines Drugs Market Value Analysis, 2015–2019

Figure 47: South Asia Injectable Benzodiazepines Drugs Market Forecast & Y-o-Y growth, 2020–2030

Figure 48: South Asia Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Country, 2020-2030

Figure 49: South Asia Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Drug Class, 2020-2030

Figure 50: South Asia Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Indication, 2020-2030

Figure 51: South Asia Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Time of Action, 2020-2030

Figure 52: South Asia Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Distribution Channel, 2020-2030

Figure 53: East Asia Injectable Benzodiazepines Drugs Market Value Analysis, 2015–2019

Figure 54: East Asia Injectable Benzodiazepines Drugs Market Forecast & Y-o-Y growth, 2020–2030

Figure 55: East Asia Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Country, 2020-2030

Figure 56: East Asia Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Drug Class, 2020-2030

Figure 57: East Asia Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Indication, 2020-2030

Figure 58: East Asia Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Time of Action, 2020-2030

Figure 59: East Asia Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Distribution Channel, 2020-2030

Figure 60: Oceania Injectable Benzodiazepines Drugs Market Value Analysis, 2015–2019

Figure 61: Oceania Injectable Benzodiazepines Drugs Market Forecast & Y-o-Y growth, 2020–2030

Figure 62: Oceania Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Country, 2020-2030

Figure 63: Oceania Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Drug Class, 2020-2030

Figure 64: Oceania Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Indication, 2020-2030

Figure 65: Oceania Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Time of Action, 2020-2030

Figure 66: Oceania Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Distribution Channel, 2020-2030

Figure 67: MEA Injectable Benzodiazepines Drugs Market Value Analysis, 2015–2019

Figure 68: MEA Injectable Benzodiazepines Drugs Market Forecast & Y-o-Y growth, 2020–2030

Figure 69: MEA Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Country, 2020-2030

Figure 70: MEA Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Drug Class, 2020-2030

Figure 71: MEA Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Indication, 2020-2030

Figure 72: MEA Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Time of Action, 2020-2030

Figure 73: MEA Injectable Benzodiazepines Drugs Market Attractiveness Analysis By Distribution Channel, 2020-2030

Figure 74: US Injectable Benzodiazepines Market Value Share, By Drug Class, 2020 (E)

Figure 75: US Injectable Benzodiazepines Market Value Share, By Indication, 2020 (E)

Figure 76: US Injectable Benzodiazepines Market Value Share, By Time of Action, 2020 (E)

Figure 77: US Injectable Benzodiazepines Market Value Share, By Distribution Channel, 2020 (E)

Figure 78: Canada Injectable Benzodiazepines Market Value Share, By Drug Class, 2020 (E)

Figure 79: Canada Injectable Benzodiazepines Market Value Share, By Indication, 2020 (E)

Figure 80: Canada Injectable Benzodiazepines Market Value Share, By Time of Action, 2020 (E)

Figure 81: Canada Injectable Benzodiazepines Market Value Share, By Distribution Channel, 2020 (E)

Figure 82: Australia Injectable Benzodiazepines Market Value Share, By Drug Class, 2020 (E)

Figure 83: Australia Injectable Benzodiazepines Market Value Share, By Indication, 2020 (E)

Figure 84: Australia Injectable Benzodiazepines Market Value Share, By Time of Action, 2020 (E)

Figure 85: Australia Injectable Benzodiazepines Market Value Share, By Distribution Channel, 2020 (E)

Figure 86: New Zealand Injectable Benzodiazepines Market Value Share, By Drug Class, 2020 (E)

Figure 87: New Zealand Injectable Benzodiazepines Market Value Share, By Indication, 2020 (E)

Figure 88: New Zealand Injectable Benzodiazepines Market Value Share, By Time of Action, 2020 (E)

Figure 89: New Zealand Injectable Benzodiazepines Market Value Share, By Distribution Channel, 2020 (E)

Figure 90: GCC Countries Injectable Benzodiazepines Market Value Share, By Drug Class, 2020 (E)

Figure 91: GCC Countries Injectable Benzodiazepines Market Value Share, By Indication, 2020 (E)

Figure 92: GCC Countries Injectable Benzodiazepines Market Value Share, By Time of Action, 2020 (E)

Figure 93: GCC Countries Injectable Benzodiazepines Market Value Share, By Distribution Channel, 2020 (E)

Figure 94: South Africa Injectable Benzodiazepines Market Value Share, By Drug Class, 2020 (E)

Figure 95: South Africa Injectable Benzodiazepines Market Value Share, By Indication, 2020 (E)

Figure 96: South Africa Injectable Benzodiazepines Market Value Share, By Time of Action, 2020 (E)

Figure 97: South Africa Injectable Benzodiazepines Market Value Share, By Distribution Channel, 2020 (E)

Figure 98: Turkey Injectable Benzodiazepines Market Value Share, By Drug Class, 2020 (E)

Figure 99: Turkey Injectable Benzodiazepines Market Value Share, By Indication, 2020 (E)

Figure 100: Turkey Injectable Benzodiazepines Market Value Share, By Time of Action, 2020 (E)

Figure 101: Turkey Injectable Benzodiazepines Market Value Share, By Distribution Channel, 2020 (E)

Figure 102: China Injectable Benzodiazepines Market Value Share, By Drug Class, 2020 (E)

Figure 103: China Injectable Benzodiazepines Market Value Share, By Indication, 2020 (E)

Figure 104: China Injectable Benzodiazepines Market Value Share, By Time of Action, 2020 (E)

Figure 105: China Injectable Benzodiazepines Market Value Share, By Distribution Channel, 2020 (E)

Figure 106: Japan Injectable Benzodiazepines Market Value Share, By Drug Class, 2020 (E)

Figure 107: Japan Injectable Benzodiazepines Market Value Share, By Indication, 2020 (E)

Figure 108: Japan Injectable Benzodiazepines Market Value Share, By Time of Action, 2020 (E)

Figure 109: Japan Injectable Benzodiazepines Market Value Share, By Distribution Channel, 2020 (E)

Figure 110: South Korea Injectable Benzodiazepines Market Value Share, By Drug Class, 2020 (E)

Figure 111: South Korea Injectable Benzodiazepines Market Value Share, By Indication, 2020 (E)

Figure 112: South Korea Injectable Benzodiazepines Market Value Share, By Time of Action, 2020 (E)

Figure 113: South Korea Injectable Benzodiazepines Market Value Share, By Distribution Channel, 2020 (E)

Figure 114: India Injectable Benzodiazepines Market Value Share, By Drug Class, 2020 (E)

Figure 115: India Injectable Benzodiazepines Market Value Share, By Indication, 2020 (E)

Figure 116: India Injectable Benzodiazepines Market Value Share, By Time of Action, 2020 (E)

Figure 117: India Injectable Benzodiazepines Market Value Share, By Distribution Channel, 2020 (E)

Figure 118: ASEAN Injectable Benzodiazepines Market Value Share, By Drug Class, 2020 (E)

Figure 119: ASEAN Injectable Benzodiazepines Market Value Share, By Indication, 2020 (E)

Figure 120: ASEAN Injectable Benzodiazepines Market Value Share, By Time of Action, 2020 (E)

Figure 121: ASEAN Injectable Benzodiazepines Market Value Share, By Distribution Channel, 2020 (E)

Figure 122: Germany Injectable Benzodiazepines Market Value Share, By Drug Class, 2020 (E)

Figure 123: Germany Injectable Benzodiazepines Market Value Share, By Indication, 2020 (E)

Figure 124: Germany Injectable Benzodiazepines Market Value Share, By Time of Action, 2020 (E)

Figure 125: Germany Injectable Benzodiazepines Market Value Share, By Distribution Channel, 2020 (E)

Figure 126: Italy Injectable Benzodiazepines Market Value Share, By Drug Class, 2020 (E)

Figure 127: Italy Injectable Benzodiazepines Market Value Share, By Indication, 2020 (E)

Figure 128: Italy Injectable Benzodiazepines Market Value Share, By Time of Action, 2020 (E)

Figure 129: Italy Injectable Benzodiazepines Market Value Share, By Distribution Channel, 2020 (E)

Figure 130: France Injectable Benzodiazepines Market Value Share, By Drug Class, 2020 (E)

Figure 131: France Injectable Benzodiazepines Market Value Share, By Indication, 2020 (E)

Figure 132: France Injectable Benzodiazepines Market Value Share, By Time of Action, 2020 (E)

Figure 133: France Injectable Benzodiazepines Market Value Share, By Distribution Channel, 2020 (E)

Figure 134: U.K. Injectable Benzodiazepines Market Value Share, By Drug Class, 2020 (E)

Figure 135: U.K. Injectable Benzodiazepines Market Value Share, By Indication, 2020 (E)

Figure 136: U.K. Injectable Benzodiazepines Market Value Share, By Time of Action, 2020 (E)

Figure 137: U.K. Injectable Benzodiazepines Market Value Share, By Distribution Channel, 2020 (E)

Figure 138: Spain Injectable Benzodiazepines Market Value Share, By Drug Class, 2020 (E)

Figure 139: Spain Injectable Benzodiazepines Market Value Share, By Indication, 2020 (E)

Figure 140: Spain Injectable Benzodiazepines Market Value Share, By Time of Action, 2020 (E)

Figure 141: Spain Injectable Benzodiazepines Market Value Share, By Distribution Channel, 2020 (E)

Figure 142: BENELUX Injectable Benzodiazepines Market Value Share, By Drug Class, 2020 (E)

Figure 143: BENELUX Injectable Benzodiazepines Market Value Share, By Indication, 2020 (E)

Figure 144: BENELUX Injectable Benzodiazepines Market Value Share, By Time of Action, 2020 (E)

Figure 145: BENELUX Injectable Benzodiazepines Market Value Share, By Distribution Channel, 2020 (E)

Figure 146: Russia Injectable Benzodiazepines Market Value Share, By Drug Class, 2020 (E)

Figure 147: Russia Injectable Benzodiazepines Market Value Share, By Indication, 2020 (E)

Figure 148: Russia Injectable Benzodiazepines Market Value Share, By Time of Action, 2020 (E)

Figure 149: Russia Injectable Benzodiazepines Market Value Share, By Distribution Channel, 2020 (E)

Figure 150: Brazil Injectable Benzodiazepines Market Value Share, By Drug Class, 2020 (E)

Figure 151: Brazil Injectable Benzodiazepines Market Value Share, By Indication, 2020 (E)

Figure 152: Brazil Injectable Benzodiazepines Market Value Share, By Time of Action, 2020 (E)

Figure 153: Brazil Injectable Benzodiazepines Market Value Share, By Distribution Channel, 2020 (E)

Figure 154: Mexico Injectable Benzodiazepines Market Value Share, By Drug Class, 2020 (E)

Figure 155: Mexico Injectable Benzodiazepines Market Value Share, By Indication, 2020 (E)

Figure 156: Mexico Injectable Benzodiazepines Market Value Share, By Time of Action, 2020 (E)

Figure 157: Mexico Injectable Benzodiazepines Market Value Share, By Distribution Channel, 2020 (E)

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[注射可能型ベンゾジアゼピンの世界市場2020年-2030年]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆